A Single-Center Long-Term Continuous Subcutaneous Insulin Infusion (CSII) Experience: Higher Fractional Use Is Associated With Less Diabetes Complications.
作者信息
Tubili Claudio, Folco Ugo Di, Nardone Maria Rosaria, Clementi Aldo
机构信息
1 Diabetes Unit, "S.Camillo-Forlanini" Hospital, Rome, Italy.
出版信息
J Diabetes Sci Technol. 2017 Sep;11(5):1057-1058. doi: 10.1177/1932296817702170. Epub 2017 Apr 3.
Abstract
摘要
相似文献
1
A Single-Center Long-Term Continuous Subcutaneous Insulin Infusion (CSII) Experience: Higher Fractional Use Is Associated With Less Diabetes Complications.
J Diabetes Sci Technol. 2017 Sep;11(5):1057-1058. doi: 10.1177/1932296817702170. Epub 2017 Apr 3.
2
Continuous subcutaneous insulin infusion (CSII) pumps.
Adv Exp Med Biol. 2012;771:414-9. doi: 10.1007/978-1-4614-5441-0_29.
3
Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
Diabetes Metab. 2011 Nov;37(5):426-31. doi: 10.1016/j.diabet.2011.02.002. Epub 2011 Apr 6.
4
Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
J Diabetes Sci Technol. 2017 May;11(3):631-632. doi: 10.1177/1932296816668375. Epub 2016 Sep 5.
5
Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.
Exp Clin Endocrinol Diabetes. 2015 Apr;123(4):260-4. doi: 10.1055/s-0034-1394381. Epub 2015 Jan 21.
6
7
Insulin pumps in hospital: a guide for the generalist physician.
Clin Med (Lond). 2013 Jun;13(3):244-7. doi: 10.7861/clinmedicine.13-3-244.
8
Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):e1-13; quiz e14-7. doi: 10.1331/JAphA.2009.08122.
9
The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
Acta Diabetol. 2010 Dec;47(4):325-30. doi: 10.1007/s00592-010-0221-5. Epub 2010 Sep 15.
10
Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
Diabetes Technol Ther. 2013 Apr;15(4):289-94. doi: 10.1089/dia.2012.0319. Epub 2013 Feb 21.
引用本文的文献
1
Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy.
Int J Mol Sci. 2023 Jul 26;24(15):11980. doi: 10.3390/ijms241511980.
2
Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits.
Curr Cardiol Rep. 2022 Dec;24(12):2043-2056. doi: 10.1007/s11886-022-01799-x. Epub 2022 Oct 24.
3
In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time.
J Diabetes Sci Technol. 2023 Nov;17(6):1563-1572. doi: 10.1177/19322968221093362. Epub 2022 May 9.
4
Predictive Low Glucose Suspend Algorithm in Real Life: A Five-Year Follow-Up Retrospective Analysis.
J Diabetes Sci Technol. 2021 Nov;15(6):1303-1307. doi: 10.1177/1932296820952107. Epub 2020 Aug 29.
本文引用的文献
1
Recent trends in life expectancy for people with type 1 diabetes in Sweden.
Diabetologia. 2016 Jun;59(6):1167-76. doi: 10.1007/s00125-016-3914-7. Epub 2016 Apr 5.
2
Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study.
BMJ. 2015 Jun 22;350:h3234. doi: 10.1136/bmj.h3234.
3
The effectiveness and durability of an early insulin pump therapy in children and adolescents with type 1 diabetes mellitus.
Diabetes Technol Ther. 2014 Nov;16(11):735-41. doi: 10.1089/dia.2014.0034. Epub 2014 Aug 27.
4
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.
Cochrane Database Syst Rev. 2010 Jan 20(1):CD005103. doi: 10.1002/14651858.CD005103.pub2.
5
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
N Engl J Med. 2005 Dec 22;353(25):2643-53. doi: 10.1056/NEJMoa052187.
Zotero 插件